Key Takeaways:
- NXT Bioscience announces acquisition of Lowes TC, introducing the AX Technology Platform.
- Innovations aim to transform plant propagation, with systems capable of producing 2,000 to 5,000 PTC plants per hour.
- The merger will enhance efficiency and sustainability in agricultural practices through advanced tissue culture technologies.
- The invitation extended to professionals and enthusiasts to join the transformative journey in plant tissue culture.
Introduction to the Merger
In a significant move for the biotechnology and agriculture industry, NXT Bioscience has announced the completion of its acquisition of Lowes TC, marking a pivotal moment for the company and the field of tissue culture technology. The merger introduces the revolutionary AX Technology Platform, promising to set new standards in plant tissue culture.
Background of Lowes TC and Its Innovations
Lowes TC, founded by renowned scientist Greg Lowe, has been forefront of tissue culture technology innovation. The company’s flagship systems, the AXR and AXL, have been instrumental in automating the tissue culture process, significantly increasing production rates and reducing costs. “These advancements have the potential to double efficiency in plant propagation,” highlighted Lowe.
Goals and Expectations Post-Merger
Daniel Mansfield, founder and CEO of NXT Bioscience, articulated the vision behind the acquisition: “We aim to accelerate the growth and enhance the market presence of both AX and TC+ technology platforms. This merger is a strategic step towards democratizing plant tissue culture technology, making it more accessible and sustainable, especially in regions with higher labor costs.”
The AX Technology Platform and TC+ Bioreactors
The AX Technology, developed with significant support from Australian Government funding, represents a breakthrough in plant tissue culture practices. When asked about the impact of this technology, Mansfield noted, “The AX platform, alongside our TC+ Bioreactors, is designed to dramatically reduce labor costs and improve operational efficiency across the board.”
NXT Bioscience’s Commitment to Sustainability and Innovation
This strategic acquisition underscores NXT Bioscience’s dedication to leading-edge solutions and its global commitment to promoting sustainable agricultural practices. “We are poised to address the pressing challenges within the horticulture, agriculture, and bio-industry sectors, providing high-quality, virus-free plant clones at an unprecedented scale,” Mansfield added.
